Epigenomics's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Epigenomics is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21
Income Statement	-
Total Revenue	$ 145.00K	$ 126.00K	$ 115.00K	$ 181.00K	$ 5.80M
Gross Profit	$ 109.00K	$ 95.00K	$ 89.00K	$ 137.00K	$ 5.75M
EBIT	$ -1.54M	$ -1.27M	$ -2.64M	$ -1.71M	$ 2.85M
EBITDA	$ -1.30M	$ -1.02M	$ -2.53M	$ -1.66M	$ 2.90M
Net Income Common Stockholders	$ -1.56M	$ -1.30M	$ -2.66M	$ -1.74M	$ 2.84M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 15.77M	$ 18.04M	$ 20.04M	$ 22.96M	$ 23.55M
Total Assets	$ 18.97M	$ 20.62M	$ 22.44M	$ 24.66M	$ 27.01M
Total Debt	$ 966.00K	$ 1.01M	$ 1.02M	$ 460.00K	$ 520.00K
Net Debt	$ -14.81M	$ -17.04M	$ -19.02M	$ -22.50M	$ -23.04M
Total Liabilities	$ 5.04M	$ 3.95M	$ 3.35M	$ 2.54M	$ 2.78M
Stockholders Equity	$ 13.93M	$ 16.67M	$ 19.09M	$ 22.12M	$ 24.23M
Cash Flow	-
Free Cash Flow	$ -2.66M	$ -2.88M	$ -3.42M	$ -580.00K	$ 617.00K
Operating Cash Flow	$ -2.48M	$ -2.67M	$ -3.27M	$ -553.00K	$ 624.00K
Investing Cash Flow	$ -152.00K	$ -203.00K	$ -134.00K	$ -24.00K	$ -8.00K
Financing Cash Flow	$ -220.00K	$ -112.00K	$ -96.00K	$ -499.00K	$ 15.60M

Currency in USD

Epigenomics Earnings and Revenue History

Income Statement >

Epigenomics Debt to Assets

Balance Sheet >

Epigenomics Cash Flow

Cash Flow >

Epigenomics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing